Novartis AG ADR Stock
€89.00
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Novartis
sharewise wants to provide you with the best news and tools for Novartis, so we directly link to the best financial data sources.
Financials
News
1 Magnificent Dividend Stock to Buy and Hold
There are plenty of dividend stocks on the market. However, some raise their payouts irregularly, while others don't have businesses that look robust enough to support payout growth for a long time
Harvard Business Professor on Failing Well
In this podcast, Motley Fool host Deidre Woollard talks about the art of failing with Amy Edmondson, the Novartis Professor of Leadership and Management at the Harvard Business School, and author of
Novartis Ag (NVS) Q4 2023 Earnings Call Transcript
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
On Nov. 28, the Food and Drug Administration (FDA) announced that it was opening an investigation into the possibility of previously unknown serious safety risks associated with the hottest and most
2 Green Flags and 1 Red Flag for Novartis Stock
Share prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular, immunology, neuroscience, solid tumors, and
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
2 Biotech Stocks That Could Make You Richer
Although sometimes risky and volatile, the biotech industry is an excellent place to find stocks that can generate steady returns for years. That's because these companies tend to offer products
3 Unstoppable Stocks to Buy and Hold for Decades
Want to invest in stocks that you can buy and forget about? If so, you'll want to consider companies with plenty of long-term growth opportunities and solid financials. Among the best growth